RxDoctor Payments Data

Leslie Fletcher

Primary Care · Torrance, CANPI 1033746359

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,488,647 of the $1,843,153 with a category attached, or 80.8%. AbbVie accounts for 100.0% of it on its own, with 3 other manufacturers making up the rest. Among primary care clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,843,153in general payments, 2019–2025

Across 2,507 payments — averaging $735.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.8M
  • Galderma Laboratories, L.p.$490
  • Revance Therapeutics, Inc.$161
  • Bayer$43

What the payments were for

  • Consulting fees$128,9617%
  • Speaking & faculty fees$1,488,64781%
  • Travel & lodging$174,9749%
  • Food & beverage$49,5893%
  • Education$9830%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)2,495$1,842,458
Galderma Laboratories, L.p.8$490
Revance Therapeutics, Inc.2$161
Bayer2$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,843,153 in reported general payments places this provider in the 95th percentile of 706 primary care providers in California.

See all primary care providers in California →

Other primary care in Torrance

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →